Business & Regulation

AI helps make preclinical decisions faster, but stakeholders remain cautious. We asked an expert from Elsevier for their views on the challenges.

AI is not just for the drug development phase of pharmaceutical manufacturing. Now is the time for the business side to leverage it.

New medicines save lives, but they take too long to get to market. Could AI make a difference?

Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.

Pharma companies are well accustomed to supply chain issues, but how prepared are they for issues impacting access to medical devices?

Celebrate a decade of pharma innovation with The Medicine Maker’s top features, from cancer vaccines to CRISPR breakthroughs.

Summarizing the updated lessons learned by the European Medicines Agency following the COVID-19 pandemic.

As 2024 draws to its conclusion, two experts look at trends in clinical trials and form predictions for 2025.

AI, the Inflation Reduction Act, and a surge in precision medicine; experts look at pharma’s future.

AI solutions can help sift through clinical trial data for effective medical writing, but more people need to use it.